PerioChip®

A biodegradable periodontal chip releasing 2.5mg Chlorhexidine Gluconate over a period of 10 days

Novel OTC formulation

Novel Formulation of a well-known US OTC Brand

Omeprazole DR Tablets

Proprietary Delayed Release Tablet Formulation of Omeprazole OTC

Complex Injectable
(Co-development)

Complex injectable product equivalent to a well-known brand in the oncology field; Co-developed with CSPC Pharma

ViePax® XR
(Venlafaxine XR tablets)

Proprietary Extended Release Tablet formulation bioequivalent to capsule Effexor XR capsules

Executive Team

The Dexcel family is made up of visionaries,

who understand how the pharmaceutical

industry influences our world and changes the

future for the better. We are always eager to

meet motivated people who share this vision

and wish to be part of our team.

Dan Oren
Founder & Executive Chairman
Ilan Oren
Co-Chief Executive Officer
Uri Oren
Co-Chief Executive Officer
Yaron Erez
Vice President,
Finance and Chief Financial Officer
Tamar Galanty
Vice President,
Head of Quality
Tomer Gold
Vice President,
Research & Development
Jonathan Grushka
Vice President, General Counsel
Ran Kreshtino
Vice President, General Manager,
Dexcel Pharma Israel
Miri Peleg
Vice President,
Chief Information Officer
Amit Rotem
Vice President,
Human Resources
Ygal Seelenfreund
Vice President,
Sales & Marketing, International
Ziv Teresh
Vice President,
Chief Operating Officer